Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
28.65
+0.30 (1.05%)
Jun 6, 2025, 1:35 PM CST
TPE:1762 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Revenue | 1,289 | 1,347 | 2,086 | 2,117 | 1,935 | 1,544 | Upgrade
|
Revenue Growth (YoY) | -18.06% | -35.42% | -1.45% | 9.43% | 25.34% | 33.45% | Upgrade
|
Cost of Revenue | 951.06 | 953.06 | 1,329 | 1,155 | 985.31 | 856.84 | Upgrade
|
Gross Profit | 337.55 | 394.32 | 757.31 | 961.76 | 949.39 | 686.75 | Upgrade
|
Selling, General & Admin | 165.84 | 182.14 | 233.8 | 271.78 | 239.89 | 202.1 | Upgrade
|
Research & Development | 194.28 | 205.84 | 242.7 | 244.79 | 252.67 | 215.73 | Upgrade
|
Operating Expenses | 360.12 | 387.98 | 476.5 | 498.23 | 510.91 | 417.83 | Upgrade
|
Operating Income | -22.57 | 6.34 | 280.81 | 463.53 | 438.48 | 268.92 | Upgrade
|
Interest Expense | -19.69 | -21.13 | -17.97 | -9.68 | -3.27 | -4.76 | Upgrade
|
Interest & Investment Income | 8.08 | 8.65 | 8.25 | 4.51 | 0.18 | 0.42 | Upgrade
|
Earnings From Equity Investments | 49.18 | 44.87 | 36.51 | 51.1 | 50.1 | 37.9 | Upgrade
|
Currency Exchange Gain (Loss) | 13.13 | 23.64 | 6.88 | 56.82 | -9.59 | -11.82 | Upgrade
|
Other Non Operating Income (Expenses) | 9.13 | 9.68 | 8.25 | 8.13 | 18.45 | 8.51 | Upgrade
|
EBT Excluding Unusual Items | 37.26 | 72.04 | 322.72 | 574.41 | 494.34 | 299.18 | Upgrade
|
Gain (Loss) on Sale of Investments | -22.19 | -15.42 | 10.77 | 9.59 | 3.27 | 4.3 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.61 | 0.61 | - | -0.7 | - | 346.83 | Upgrade
|
Pretax Income | 15.69 | 57.22 | 333.49 | 583.31 | 497.61 | 650.3 | Upgrade
|
Income Tax Expense | -4.11 | 4.19 | 68.58 | 117.17 | 96.56 | 118.23 | Upgrade
|
Earnings From Continuing Operations | 19.8 | 53.03 | 264.91 | 466.14 | 401.05 | 532.06 | Upgrade
|
Minority Interest in Earnings | - | - | - | -0.28 | -0.27 | -0.19 | Upgrade
|
Net Income | 19.8 | 53.03 | 264.91 | 465.87 | 400.78 | 531.87 | Upgrade
|
Net Income to Common | 19.8 | 53.03 | 264.91 | 465.87 | 400.78 | 531.87 | Upgrade
|
Net Income Growth | -84.32% | -79.98% | -43.14% | 16.24% | -24.65% | 354.58% | Upgrade
|
Shares Outstanding (Basic) | 51 | 56 | 78 | 78 | 78 | 78 | Upgrade
|
Shares Outstanding (Diluted) | 51 | 56 | 78 | 79 | 78 | 78 | Upgrade
|
Shares Change (YoY) | -34.91% | -27.92% | -0.52% | 0.23% | -0.02% | 0.16% | Upgrade
|
EPS (Basic) | 0.39 | 0.95 | 3.42 | 6.01 | 5.17 | 6.86 | Upgrade
|
EPS (Diluted) | 0.39 | 0.94 | 3.39 | 5.93 | 5.12 | 6.79 | Upgrade
|
EPS Growth | -76.09% | -72.27% | -42.83% | 15.82% | -24.59% | 352.67% | Upgrade
|
Free Cash Flow | 683.52 | 364.57 | -516.27 | 359.12 | -184.18 | -53.38 | Upgrade
|
Free Cash Flow Per Share | 13.46 | 6.48 | -6.61 | 4.58 | -2.35 | -0.68 | Upgrade
|
Dividend Per Share | 0.190 | 0.190 | 0.800 | 1.300 | 1.300 | 1.500 | Upgrade
|
Dividend Growth | -76.25% | -76.25% | -38.46% | - | -13.33% | 87.50% | Upgrade
|
Gross Margin | 26.20% | 29.27% | 36.30% | 45.43% | 49.07% | 44.49% | Upgrade
|
Operating Margin | -1.75% | 0.47% | 13.46% | 21.89% | 22.66% | 17.42% | Upgrade
|
Profit Margin | 1.54% | 3.94% | 12.70% | 22.00% | 20.71% | 34.46% | Upgrade
|
Free Cash Flow Margin | 53.04% | 27.06% | -24.74% | 16.96% | -9.52% | -3.46% | Upgrade
|
EBITDA | 175.19 | 205.5 | 473.81 | 632.58 | 570.47 | 400.07 | Upgrade
|
EBITDA Margin | 13.59% | 15.25% | 22.71% | 29.88% | 29.49% | 25.92% | Upgrade
|
D&A For EBITDA | 197.76 | 199.16 | 193.01 | 169.05 | 131.99 | 131.15 | Upgrade
|
EBIT | -22.57 | 6.34 | 280.81 | 463.53 | 438.48 | 268.92 | Upgrade
|
EBIT Margin | -1.75% | 0.47% | 13.46% | 21.89% | 22.66% | 17.42% | Upgrade
|
Effective Tax Rate | - | 7.32% | 20.56% | 20.09% | 19.41% | 18.18% | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.